دورية أكاديمية
Virtual town halls addressing vaccine hesitancy among racial/ethnic minorities: Preliminary findings.
| العنوان: | Virtual town halls addressing vaccine hesitancy among racial/ethnic minorities: Preliminary findings. |
|---|---|
| المؤلفون: | Wagner EF, Langwerden RJ, Morris SL, Ward MK, Trepka MJ, Campa AL, Howard MM, Charles SC, Garba NA, Hospital MM |
| المصدر: | Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2022 Jan-Feb; Vol. 62 (1), pp. 317-325. Date of Electronic Publication: 2021 Nov 10. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1544-3450 (Electronic) Linking ISSN: 10865802 NLM ISO Abbreviation: J Am Pharm Assoc (2003) Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2016- : New York : Elsevier Original Publication: Washington, DC : American Pharmacists Association, c2003- |
| مواضيع طبية MeSH: | COVID-19* , Ethnic and Racial Minorities*, Adult ; COVID-19 Vaccines ; Ethnicity ; Female ; Humans ; Male ; Minority Groups ; SARS-CoV-2 ; Vaccination ; Vaccination Hesitancy |
| مستخلص: | Background: The coronavirus disease 2019 (COVID-19) pandemic remains a public health priority, and vaccination is important for ending the pandemic. Racial and ethnic minorities are disproportionally affected by COVID-19 yet report high levels of vaccination hesitancy. Objective: We conducted virtual town halls to address vaccine hesitancy among racial and ethnic minorities in South Florida. Methods: Our approach used social influence and persuasion models. In a formative phase, we gathered meeting preferences from our communities and developed and tested our approach. In an implementation phase, we conducted 6 virtual town halls in partnership with minority community-based organizations. Results: The town halls reached 383 participants (mean age 37.5 years; 63.4% female, 33.9% male, 2.7% nonbinary; 59% racial/ethnic minority) who completed pre- and postmeeting assessments. Among nonvaccinated participants, at the prepoll, 58% reported a high likelihood of seeking vaccination, rising to 63% at the postassessment. Unvaccinated non-hesitant and hesitant groups were compared on trusted information sources and reasons and barriers for vaccination. Nonhesitant participants reported significantly greater trust in the COVID-19 Task Force (97.3% vs. 83.3%) as a source of vaccine information than did hesitant participants. Nonhesitant participants were significantly more likely to endorse family safety (82.5% vs. 63.2%), community safety (72.5% vs. 26.3%), personal safety (85% vs. 36.8%), and wanting to return to a normal life (70% vs. 31.6%) as reasons for vaccination than were hesitant participants. Hesitant participants were significantly more likely to endorse concerns about vaccine safety doubts (63.2% vs. 17.5%) and not believing the pandemic is as bad as people say it is (21.1% vs. 5%) as barriers to vaccination than were nonhesitant participants. Qualitative data revealed high consumer satisfaction with the town halls. Conclusion: This study supports the feasibility, acceptability, and potential impact of virtual town halls for addressing vaccine hesitancy among racial/ethnic minorities; however, our approach was resource intensive, required an extensive community-university collaborative infrastructure, and yielded a small effect. (Copyright © 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.) |
| التعليقات: | Erratum in: J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1446-1450. (PMID: 35803667) |
| References: | Ann Intern Med. 2020 Dec 15;173(12):964-973. (PMID: 32886525) Nat Hum Behav. 2021 Mar;5(3):337-348. (PMID: 33547453) Nutrients. 2020 Jul 15;12(7):. (PMID: 32679788) J Public Health Policy. 2020 Dec;41(4):410-420. (PMID: 32826935) IEEE Trans Vis Comput Graph. 2009 Nov-Dec;15(6):1137-44. (PMID: 19834182) EClinicalMedicine. 2021 Apr;34:100834. (PMID: 33880441) N Engl J Med. 2020 Jul 16;383(3):201-203. (PMID: 32374952) J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207. (PMID: 33196555) Lancet. 2020 Apr 18;395(10232):1243-1244. (PMID: 32305087) JAMA. 2020 May 19;323(19):1891-1892. (PMID: 32293639) Psychiatry Res. 2020 Jun;288:113031. (PMID: 32360895) Annu Rev Psychol. 2000;51:539-70. (PMID: 10751980) JAMA. 2020 Jun 23;323(24):2466-2467. (PMID: 32391864) Vaccines (Basel). 2020 Oct 03;8(4):. (PMID: 33022917) Health Equity. 2020 Oct 30;4(1):476-483. (PMID: 33269331) Nutrients. 2020 Jun 02;12(6):. (PMID: 32498323) Transl Behav Med. 2021 Jul 29;11(7):1354-1358. (PMID: 34080616) J Community Health. 2021 Apr;46(2):270-277. (PMID: 33389421) BMJ. 2020 Apr 14;369:m1483. (PMID: 32291262) |
| معلومات مُعتمدة: | U54 MD012393 United States MD NIMHD NIH HHS |
| المشرفين على المادة: | 0 (COVID-19 Vaccines) |
| تواريخ الأحداث: | Date Created: 20220108 Date Completed: 20220112 Latest Revision: 20220830 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC8590854 |
| DOI: | 10.1016/j.japh.2021.11.005 |
| PMID: | 34996576 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1544-3450 |
|---|---|
| DOI: | 10.1016/j.japh.2021.11.005 |